FDA Approves XCOPRI® (cenobamate tablets), an Anti-Epileptic Drug (AED) from SK Biopharmaceuticals, Co., Ltd., and U.S. Subsidiary SK Life Science, Inc.

The FDA approval of XCOPRI for the treatment of partial-onset seizures is a welcome option for the epilepsy community."